Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

iTRUST

Financiado

Cerrado

iTRUST In time TReatment of acUte ischaemic STroke

The problem: Intravenous thrombolysis is by far the most effective treatment of Acute Ischaemic Stroke (AIS), and its use can independently strongly increase the proportion of AIS patients surviving. However, in the emergency sett... ver más

31/07/2017

Mindway AI

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

CERCARE MEDICAL APS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-07-31

SMEInst-06-2016-2017: Accelerating market introduction of...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Mindway AI

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

iTrust In time TReatment of acUte ischaemic STroke 3M€ Cerrado

TreatStroke arTificial neuRal nEtwork prediction of hAemorrhagic Transfo... 114K€ Cerrado

ERYTHROAG A new ICT based device RHEO 01 for fast point of care anal... 71K€ Cerrado

MAESTRIA Machine Learning Artificial Intelligence Early Detection Str... 15M€ Cerrado

DECIMAL DETECTION OF CEREBRAL ISCHEMIA BASED ON MACHINE LEARNING 138K€ Cerrado

VALIDATE V A L I D A T E - Validation of a Trustworthy AI-based Clin... 6M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2017-01-25
Fecha Fin: 2017-07-31

Líder del proyecto

CERCARE MEDICAL APS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The problem: Intravenous thrombolysis is by far the most effective treatment of Acute Ischaemic Stroke (AIS), and its use can independently strongly increase the proportion of AIS patients surviving. However, in the emergency setting of AIS an excess of information must be considered by the physician including imaging, clinical presentation and electronic health record data before safely inferring on the suitability of thrombolytic therapy. Still, the therapeutic decision is largely dependent on the capacity of the expert radiologist in predicting what is the outcome for the given patient after applying the pharmacological treatment – a problem further compounded by the heterogeneity in AIS progression. The solution: iTRUST solution is a clinical decision support system that uses Convolutional Neural Networks to predict the outcome of the AIS for each patient based on the patient’s biomarkers as well as clinical information. The prediction is presented as a probability of infarction when using pharmacological treatment or mechanical recanalization, making the prediction much more useful compared to current methods. The market: The global AIS diagnosis and treatment market was valued at USD 1.2 billion in 2013 and is estimated to reach a market worth of USD 1.9 billion in 2020 growing at a CAGR of 6.3% from 2014 to 2020. Given the high incidence of AIS cases and the high importance of quickly allocating the appropriate therapeutic intervention, we have reasons to believe that iTRUST solution can generate an accumulated turnover exceeding EUR 32 million, five years post-project.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores